Drugs / AS1986NS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06906471 | Jul → Oct 2026 expected | prostate adenocarcinoma | Antelope Surgical Solutions, Inc | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AS1986NS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06906471 ↗ |
| Route | Intravenous | “administered as an injection through peripheral intravenous access.” NCT06906471 ↗ |